Pharmacogenomics of β-blockers and statins: possible implications for perioperative cardiac complications

J Cardiothorac Vasc Anesth. 2012 Dec;26(6):1101-14. doi: 10.1053/j.jvca.2012.06.025. Epub 2012 Aug 11.

Authors

Miklos D Kertai¹, Manuel Fontes, Mihai V Podgoreanu

Affiliation

¹ Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA. miklos.kertai@duke.edu

PMID: 22889606
DOI: 10.1053/j.jvca.2012.06.025

No abstract available

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / adverse effects*
Animals
Heart Diseases / chemically induced
Heart Diseases / genetics*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Perioperative Care / adverse effects*
Perioperative Care / methods
Pharmacogenetics / methods*
Pharmacogenetics / trends

Substances

Adrenergic beta-Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors